세계의 노상 약물 검사 기기 시장 규모 : 샘플 유형별, 물질별, 최종 사용자별, 지역 범위별 및 예측

Roadside Drug Testing Devices Market Size And Forecast

Roadside Drug Testing Devices Market size was valued at USD 460.72 Million in 2024 and is projected to reach USD 696.41 Million by 2032, growing at a CAGR of 5.30% during the forecast period 2026-2032.

The global market for roadside drug testing devices is expected to rise due to strict law enforcement, rising drug, and alcohol use among young and older people, and an alarming number of fatalities from drunk-driving incidents. The Global Roadside Drug Testing Devices Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors playing a substantial role in the market.

Global Roadside Drug Testing Devices Market Definition

Roadside drug tests By analyzing biological samples, including hair, blood, and urine, devices are used to detect the presence of drugs or their metabolites in a person's body. The widely used testing portfolio for drugs and alcohol consists of laboratory tests, tests run on fast analyzers, immunoassay components, and visual-read screening tools. This testing aids law enforcement efforts to rapidly remove suspect drivers off the road who have used drugs or alcohol. Government officials worldwide are gravely concerned about the rising frequency of fatal accidents involving drunk drivers.

Global Roadside Drug Testing Devices Market Overview

Globally, legislation governing more regularly employed roadside drug testing equipment has been improved due to the growing emphasis on ensuring motor vehicle safety. These devices allow using the accused's body fluid samples in roadside drug testing. The need for roadside drug testing equipment among law enforcement organizations has significantly increased due to the development of quick drug abuse detection technologies. The ease and precision of using such portable equipment immediately are the primary factors driving the demand for roadside drug testing devices.

The roadside drug testing equipment market is expected to expand as customers become more aware of government policies, regulations, and strict law enforcement. During the forecast period, the adoption of fast test devices for drug and alcohol testing or identification is anticipated to boost the worldwide market for roadside drug testing equipment. Devices that test for drugs on the side of the road are becoming more and more necessary due to increased traffic accidents. Equipment for roadside drug testing is frequently sold in developed and developing nations.

The rise in drink-spiking at amusement events also presents a sizable development opportunity for the roadside drug testing equipment market. However, poor or false-negative detection brought on by biological samples, such as bodily fluids, obtained from the victim's body afterwards may hurt roadside drug testing equipment sales. The gadget's operation in cold weather settings is the main factor limiting the market share growth of roadside drug testing devices.

Global Roadside Drug Testing Devices Market Segmentation Analysis

The Global Roadside Drug Testing Devices Market is segmented on the basis of Sample Type, Substance, End-User, and Geography.

Roadside Drug Testing Devices Market, By Sample Type

• Saliva
• Breath
• Sweat
• Others
• On the basis of Sample Type, the market is segmented into Saliva, Breath, Sweat, and Others. The Breath segment is anticipated to dominate the Global market due to widespread availability, new product introductions, and endorsement.

Roadside Drug Testing Devices Market, By Substance

• Drugs
• Alcohol
• On the basis of Substance, the market is segmented into Drugs and Alcohol. The Alcohol segment is anticipated to dominate the Global market. This is due to alcohol being the substance that drivers abuse the most frequently. The increased public health effects of alcohol abuse and the legalization of equipment for roadside drug testing also contribute to the growth of the worldwide market.

Roadside Drug Testing Devices Market, By End-User

• Highway Police
• Drug Enforcement Agencies
• On the basis of End-User, the market is segmented into Highway Police and Drug Enforcement Agencies. The Highway Police segment is anticipated to dominate the Global market due to the increased number of people using drugs and alcohol while operating a motor vehicle.

Roadside Drug Testing Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the world. North America will hold the largest Global Roadside Drug Testing Devices market because excessive alcohol use is a big concern. Additionally, drug testing is encouraged by rising illegal drug usage, strict laws across the nation, and the funds the government has made available to fight drug addiction.

Key Players

The "Global Roadside Drug Testing Devices Market" study report will provide valuable insight emphasizing the global market. The major players in the market are Quest Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Inc., Siemens Healthineers, LabCorp, Dragerwerk AG & Co. KgaA, AK GlobalTech Corporation, MAVAND Solutions GmbH, Oranoxis Inc., Pacific Data Systems Pty Ltd, CareHealth America, UriTox, LLC, Cannabix Technologies Inc., and Alcohol Countermeasure Systems Corp.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Key Developments

• In August 2021, Select Health of South Carolina and Quest Diagnostics agreed to serve Medicaid and Medicare Medicaid dual-eligible enrollees better and increase member access to diagnostic information services.
• Ace Matrix Analysis
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.
• Market Attractiveness
• The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Roadside Drug Testing Devices Market. We cover the major impacting factors driving the industry growth in the given region.
• Porter's Five Forces
• The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Roadside Drug Testing Devices Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET

• 1.1 Market Definition
• 1.2 Market Segmentation
• 1.3 Research Timelines
• 1.4 Assumptions
• 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 2.1 Data Mining
• 2.2 Data Triangulation
• 2.3 Bottom-Up Approach
• 2.4 Top-Down Approach
• 2.5 Research Flow
• 2.6 Key Insights from Industry Experts
• 2.7 Data Sources

3 EXECUTIVE SUMMARY

• 3.1 Market Overview
• 3.2 Ecology Mapping
• 3.3 Absolute Market Opportunity
• 3.4 Market Attractiveness
• 3.5 Global Roadside Drug Testing Devices Market Geographical Analysis (CAGR %)
• 3.6 Global Roadside Drug Testing Devices Market, By Sample Type (USD Million)
• 3.7 Global Roadside Drug Testing Devices Market, By Substance (USD Million)
• 3.8 Global Roadside Drug Testing Devices Market, By End-User (USD Million)
• 3.9 Future Market Opportunities
• 3.10 Global Market Split
• 3.11 Product Life Line

4 GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET OUTLOOK

• 4.1 Global Roadside Drug Testing Devices Evolution
• 4.2 Drivers
  • 4.2.1 Driver1
  • 4.2.2 Driver 2
• 4.3 Restraints
  • 4.3.1 Restraint1
  • 4.3.2 Restraint 2
• 4.4 Opportunities
  • 4.4.1 Opportunity1
  • 4.4.2 Opportunity 2
• 4.5 Porters Five Force Model
• 4.6 Value Chain Analysis
• 4.7 Pricing Analysis
• 4.8 Macroeconomic Analysis

5 GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET, BY Sample Type

• 5.1 Overview
• 5.2 Saliva
• 5.3 Breath
• 5.4 Sweat
• 5.5 Others

6 GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET, BY Substance

• 6.1 Overview
• 6.2 Drugs
• 6.3 Alcohol

7 GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET, BY End-User

• 7.1 Overview
• 7.2 Highway Police
• 7.3 Drug Enforcement Agencies

8 GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Argentina
  • 8.5.3 Rest of Latin America
• 8.6 Middle-East and Africa
  • 8.6.1 UAE
  • 8.6.2 Saudi Arabia
  • 8.6.3 South Africa
  • 8.6.4 Rest of Middle-East and Africa

9 GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Developments
• 9.4 Company Regional Footprint
• 9.5 Company Industry Footprint
• 9.6 ACE Matrix

10 COMPANY PROFILES

• 10.1 Quest Diagnostics
  • 10.1.1 Company Overview
  • 10.1.2 Company Insights
  • 10.1.3 Product Benchmarking
  • 10.1.4 Key Development
  • 10.1.5 Winning Imperatives
  • 10.1.6 Current Focus & Strategies
  • 10.1.7 Threat from Competition
  • 10.1.8 SWOT Analysis
• 10.2 Abbott Laboratories
  • 10.2.1 Company Overview
  • 10.2.2 Company Insights
  • 10.2.3 Product Benchmarking
  • 10.2.4 Key Development
  • 10.2.5 Winning Imperatives
  • 10.2.6 Current Focus & Strategies
  • 10.2.7 Threat from Competition
  • 10.2.8 SWOT Analysis
• 10.3 Thermo Fisher Scientific, Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Company Insights
  • 10.3.3 Product Benchmarking
  • 10.3.4 Key Development
  • 10.3.5 Winning Imperatives
  • 10.3.6 Current Focus & Strategies
  • 10.3.7 Threat from Competition
  • 10.3.8 SWOT Analysis
• 10.4 Siemens Healthineers
  • 10.4.1 Company Overview
  • 10.4.2 Company Insights
  • 10.4.3 Product Benchmarking
  • 10.4.4 Key Development
  • 10.4.5 Winning Imperatives
  • 10.4.6 Current Focus & Strategies
  • 10.4.7 Threat from Competition
  • 10.4.8 SWOT Analysis
• 10.5 LabCorp
  • 10.5.1 Company Overview
  • 10.5.2 Company Insights
  • 10.5.3 Product Benchmarking
  • 10.5.4 Key Development
  • 10.5.5 Winning Imperatives
  • 10.5.6 Current Focus & Strategies
  • 10.5.7 Threat from Competition
  • 10.5.8 SWOT Analysis
• 10.6 Dragerwerk AG & Co. KgaA
  • 10.6.1 Company Overview
  • 10.6.2 Company Insights
  • 10.6.3 Product Benchmarking
  • 10.6.4 Key Development
  • 10.6.5 Winning Imperatives
  • 10.6.6 Current Focus & Strategies
  • 10.6.7 Threat from Competition
  • 10.6.8 SWOT Analysis
• 10.7 AK GlobalTech Corporation
  • 10.7.1 Company Overview
  • 10.7.2 Company Insights
  • 10.7.3 Product Benchmarking
  • 10.7.4 Key Development
  • 10.7.5 Winning Imperatives
  • 10.7.6 Current Focus & Strategies
  • 10.7.7 Threat from Competition
  • 10.7.8 SWOT Analysis
• 10.8 MAVAND Solutions GmbH
  • 10.8.1 Company Overview
  • 10.8.2 Company Insights
  • 10.8.3 Product Benchmarking
  • 10.8.4 Key Development
  • 10.8.5 Winning Imperatives
  • 10.8.6 Current Focus & Strategies
  • 10.8.7 Threat from Competition
  • 10.8.8 SWOT Analysis
• 10.9 Oranoxis Inc.
  • 10.9.1 Company Overview
  • 10.9.2 Company Insights
  • 10.9.3 Product Benchmarking
  • 10.9.4 Key Development
  • 10.9.5 Winning Imperatives
  • 10.9.6 Current Focus & Strategies
  • 10.9.7 Threat from Competition
  • 10.9.8 SWOT Analysis
• 10.10 Pacific Data Systems Pty Ltd
  • 10.10.1 Company Overview
  • 10.10.2 Company Insights
  • 10.10.3 Product Benchmarking
  • 10.10.4 Key Development
  • 10.10.5 Winning Imperatives
  • 10.10.6 Current Focus & Strategies
  • 10.10.7 Threat from Competition
  • 10.10.8 SWOT Analysis
• 10.11 CareHealth America
  • 10.11.1 Company Overview
  • 10.11.2 Company Insights
  • 10.11.3 Product Benchmarking
  • 10.11.4 Key Development
  • 10.11.5 Winning Imperatives
  • 10.11.6 Current Focus & Strategies
  • 10.11.7 Threat from Competition
  • 10.11.8 SWOT Analysis
• 10.12 UriTox, LLC
  • 10.12.1 Company Overview
  • 10.12.2 Company Insights
  • 10.12.3 Product Benchmarking
  • 10.12.4 Key Development
  • 10.12.5 Winning Imperatives
  • 10.12.6 Current Focus & Strategies
  • 10.12.7 Threat from Competition
  • 10.12.8 SWOT Analysis
• 10.13 Cannabix Technologies Inc.
  • 10.13.1 Company Overview
  • 10.13.2 Company Insights
  • 10.13.3 Product Benchmarking
  • 10.13.4 Key Development
  • 10.13.5 Winning Imperatives
  • 10.13.6 Current Focus & Strategies
  • 10.13.7 Threat from Competition
  • 10.13.8 SWOT Analysis
• 10.14 Alcohol Countermeasure Systems Corp.
  • 10.14.1 Company Overview
  • 10.14.2 Company Insights
  • 10.14.3 Product Benchmarking
  • 10.14.4 Key Development
  • 10.14.5 Winning Imperatives
  • 10.14.6 Current Focus & Strategies
  • 10.14.7 Threat from Competition
  • 10.14.8 SWOT Analysis

11. VERIFIED MARKET INTELLIGENCE

• 11.1 About Verified Market Intelligence
• 11.2 Dynamic Data Visualization